复发难治性多发性骨髓瘤的治疗新进展  

Treatment strategies for relapsed and refractory multiple myeloma

作　　者：殷娜[1] 刘申婷 何明生[1] Yin Na;Liu Shenting;He Mingsheng(The Third Affiliated Hospital o f Kunming Medical University, The Tumor Hospital o f Yunnan Province, Yunnan Kunming 652118, China)

机构地区：[1]昆明医科大学第三附属医院,云南省肿瘤医院,云南昆明650118

出　　处：《现代肿瘤医学》2016年第14期2305-2308,共4页Journal of Modern Oncology

摘　　要：多发性骨髓瘤(MM)是一种不可治愈的恶性浆细胞疾病,且几乎所有的患者最终都会出现复发及耐药。目前尚无针对复发难治性MM的标准治疗方案。近年来,关于药物治疗、造血干细胞移植治疗有了新的进展,本文就近年来新的治疗进展综述如下。Multiple myeloma (MM) is a malignancy of plasma cells'which is still incurable now. Almost all MM pa-tients inevitably relapse or develop refractory diseases. At present,a generally accepted standard treatment plan for re-lapsed and refractory MM patients is still unavailable. This article provides an overview of various treatment strategies,including new drugs,stem cell transplantation which have been available over the past years for RRMM

关 键 词：多发性骨髓瘤 复发 难治 新药 干细胞移植 

分 类 号：R733.3[医药卫生—肿瘤]